The Weight Loss Cure They Don’t Want You To Know About By Kevin Trudeau
August 26, 2010 in Fitness by weightladder
You are browsing the category for FDA.
P&G Backs Somaxon for Launch of New Sleep Drug
August 26, 2010 in Sleep Disorders by sleepzine
Somaxon has gotten a big boost after Proctor & Gamble promised to help them sell Silenor to thousands of U.S. doctors and pharmacies. Both companies have agreed in principle to start the marketing efforts for the new sleep drug this September.
The deal also places Procter & Gamble first in line to negotiate for the rights to develop and market an over-the-counter…
The Second Agreement: Don’t Take Anything Personally
June 6, 2010 in Mental Health by psychcentral
Don’t take anything personally.
That’s the second agreement of Don Miguel Ruiz’s classic, “The Four Agreements.”
I need a reminder today. So I open his book to that chapter and read:
Whatever happens around you, don’t take it personally… Nothing other people do is because of you. It is because of themselves. All people live in their own dream, in their own mind; they are in…
Astra-Zeneca Settles Drug Issue in Wisconsin
May 11, 2010 in Sleep Disorders by sleepzine
Wisconsin got a multi-state settlement from drug maker Astra-Zeneca for marketing an anti-psychotic drug which did not gain FDA approval. The said drug was aimed towards treating sleep problems such as insomnia and other psychiatric conditions.
Astra-Zeneca denied these claims and chose to settle the issue rather than let the drug issue get out of hand. At $4 million, that was indeed some issue which cost them a lot…
Jet Lag Drug Stalled
April 3, 2010 in Sleep Disorders by sleepzine
Nuvigil has been declined for approval by the U.S. Health regulators after some questionable data in making the said Cephalon sleep disorder drug. Nuvigil is a successor to Provigil and was introduced last June. Cephalon received a response letter of denial to approve the drug for jet lag this time.
According to the Centers for Disease Control and Prevention Agency in U.S, Jet Lag is a condition marked by a…
Non-Abusable FDA Treatment Cleared by FDA
March 20, 2010 in Sleep Disorders by sleepzine
Somaxon Pharmaceuticals Inc. got approval for its insomnia drug Silenor after three tries from the FDA. The company had initially sent their drug application as early as January, 2008 which eventually got declined. Somaxon resubmitted its application on January 21, 2010, which was considered as Class 1 resubmission with a two-month review cycle resulting in a decision date by March 21, 2010.
Silenor has not been designated as…